About: Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2000 (uk) im Juli 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2000 (ast) scientific article published on 01 July 2000 (en)
publication date	wds:Q73902432-2A7037EA-E1D2-4D6A-B3C2-4D3DF6BC023D
publication date	2000-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73902432-6AA8D049-B0E3-46DD-A015-09E15E49DD90
language of work or name	English
cites work	wds:Q73902432-1395EA47-B61F-4A5E-BDA0-FFA936C7C7D6 wds:Q73902432-22D0F2F2-1B21-4F14-882A-07CD3D68FA6B wds:Q73902432-2424B4D7-0806-42E1-BE21-8B1A4908AD94 wds:Q73902432-2AD939A9-1039-42FA-91EE-23C8AF97B9CE wds:Q73902432-2C97301F-C8F1-4300-9BCD-9A65FE534DCD wds:Q73902432-322B3BF3-EA61-456F-AE94-ADB59EA52977 wds:Q73902432-3999F3AA-8A7A-4A6E-A69F-6F3EFEF4B54B wds:Q73902432-40A13A8F-C5FE-45A3-91D8-2A9B51848BA1 wds:Q73902432-44FC1A90-0DB5-4853-ACF5-95FBA7304A20 wds:Q73902432-467DC24B-AB84-4906-A6F5-120798F9FE3E wds:Q73902432-5069DE29-C0B3-4A7A-B553-DAC61ABE9C06 wds:Q73902432-6DC0E18A-0130-415C-B3D0-57678BA98D24 wds:Q73902432-6FD27AAD-B687-46B6-A8EC-CC30BC77E6F0 wds:Q73902432-7ABCBD1C-1904-4585-AFD2-A6E88EB02CF2 wds:Q73902432-7E9FB9FD-82E2-4F06-AB78-5201FC0E935D wds:Q73902432-87B17896-4696-46EE-9571-DC5854679BE1 wds:Q73902432-9CFB64B5-0DCB-4C7D-B907-6974D1F893DD wds:Q73902432-BD049BA8-29AF-4A59-AED7-20312BD27D13 wds:Q73902432-BD1FA6CF-A8B7-4BFC-838B-7B115F5895E6 wds:Q73902432-C5561A55-9F9C-4074-AC2E-B65E4FB6EBE1 wds:Q73902432-CFD53593-6297-4D1E-8A14-94B57450F41D wds:Q73902432-DB776676-E8D5-4D85-A35B-ECA8B0DB8045 wds:Q73902432-DF32FB7C-A061-4073-A883-34E5357D1FA0 wds:Q73902432-E7195371-3365-4573-A802-93A63CD4DBAB wds:Q73902432-FB680444-9ACB-44AA-9A50-EB31D7F707EA wds:Q73902432-FC413795-A1C4-49EB-A572-6B2049C32A17 wds:Q73902432-FFB8656F-97C3-4E5F-BF4A-DBE2A3376268
cites work	Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations Rubella immunity. Defining the level of protective antibody Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up Persistence of rubella antibodies 15 years after subcutaneous administration of Wistar 27/3 strain live attenuated rubella virus vaccine Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination Mass vaccination programme aimed at eradicating measles, mumps, and rubella in Sweden: first experience Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months. Rubella Immunity and Morbidity: Effects of Vaccination in Finland Hemolysis-in-gel test in immunity surveys and diagnosis of rubella Rubella immunity and morbidity: impact of different vaccination programs in Finland 1979-1992. Viremia, Virus Excretion, and Antibody Responses after Challenge in Volunteers with Low Levels of Antibody to Rubella Virus Serological evidence of reinfection among vaccinees during rubella outbreak Possibility of reinfection after immunisation with RA27/3 live attenuated rubella virus Duration of immunity after rubella vaccination: a long-term study in Switzerland Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination Rubella vaccination: persistence of antibodies for 10-21 years Rubella antibody persistence after immunization No measles in Finland Rubella vaccines: past, present and future Serological response to rubella revaccination Persistence of humoral and cell-mediated immunity to rubella virus in cloistered nuns and in schoolteachers
author name string	wds:Q73902432-7623C257-052B-4AD5-8A0D-EEA32C968124 wds:Q73902432-7AC89528-F9C7-4EBB-B98C-C6026756245D wds:Q73902432-89992178-CBCD-4C31-8E5F-80DDE05A006B wds:Q73902432-A5187521-FB41-4633-8200-8043CEC8FA51
author name string	H Peltola M Valle I Davidkin P Leinikki
rdfs:label	Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland (en) Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland (nl)
skos:prefLabel	Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland (en) Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland (nl)
name	Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland (en) Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland (nl)
title	wds:Q73902432-B7B77FE2-117F-42CB-9B86-0B361F026C83
title	Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland (en)
page(s)	wds:Q73902432-08EF0727-808E-44FA-829E-91E8E4D5353C
page(s)	3106-3112
instance of	wds:Q73902432-1DAFEE41-BFAC-47F6-A12A-EECAB5C0E759
instance of	scholarly article
main subject	wds:Q73902432-1DE1EFD8-DCEF-43BF-AA43-2EF50880AA45 wds:Q73902432-8887974F-3623-4BEB-AEB0-CE59F5F1AA8D wds:Q73902432-8EDDD1EE-BB7D-49ED-BFEB-D95AB5CB8034 wds:Q73902432-DCF8883A-D181-4F7B-860F-D228DF905B40
main subject	mumps Finland measles rubella
PubMed ID	wds:Q73902432-60A6B3FB-A229-42A1-97A9-480A4126158A
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10856790
PubMed ID	10856790
published in	wds:Q73902432-1B9B446A-3A49-45E6-8DA6-839032845138
published in	Vaccine
issue	wds:Q73902432-D1B09158-FF9F-46FA-8B94-6CA8FE1B1E14
volume	wds:Q73902432-5DC78927-5CA7-4934-A82D-E66398893F48
issue	27

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software